Search results
Tacholiquin, a sterile solution administered via inhalation since 1960 in Europe is currently available in Malaysia and South East Asia. Meet the key to keep breathing freely without affecting your respiratory muco-clearance physiological mechanism.
Tacholiquin ® 1% solution is intended for the adjunctive treatment of a variety of airways and lung disorders associated with the formation of viscous sputum: Acute and chronic irritation of the respiratory tract
Tyloxapol is the main active ingredient of the medical device Tacholiquin. Tacholiquin is an expectorant designated for inhalation and instillation reaching the upper and lower airways. Other brand names of pharmaceutical products containing Tyloxapol are Exosurf and Alevaire.
Jun 16, 2016 · In the study, we used Tacholiquin ® (bene-Arzneimittel GmbH, München Germany) containing 1% Tyloxapol, 5% glycerine and 2% sodium hydrogen carbonate in a sterile aqueous solution and saline 0.9% solution.
May 27, 2022 · Tacholiquin 1%-Solution reduces the surface tension on the mucous membranes of the respiratory tract using a physical mechanism, which loosens tough masses of mucus and secretions and facilitates their removal. Tacholiquin 1%-Solution contains tyloxapol, which is a non-ionic wetting agent.
tacholiquin ® 1% respiratory diseases solution for a nebuliser Mucus. Pack size: 10X5 ml. solution for respiratory diseases. tacholiquin 1% solution has been used for more than 60 years to dissolve mucus in diseases of the respiratory tract.
Tacholiquin ® is a mucus-dissolving preparation (mucolytic) which has been used successfully for more than 50 years. It is suitable for treating all respiratory tract diseases associated with thick mucus formation and is particularly well tolerated by all age groups.
